Welcome to our dedicated page for Ingersoll-Rand SEC filings (Ticker: IR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions. These filings offer detailed information on the company’s operations, governance, and financial performance across its Industrial Technologies and Services and Precision and Science Technologies segments.
Ingersoll Rand regularly files Current Reports on Form 8-K to disclose material events. Recent 8-K filings include reports on quarterly financial results, where the company furnishes earnings press releases that discuss segment orders, revenues, Adjusted EBITDA, and guidance, as well as filings related to board changes. For example, the company has filed 8-Ks describing the appointment of new independent directors and their committee assignments, including roles on the Compensation, Sustainability, and Nominating and Corporate Governance Committees.
Through this filings page, users can also review documents that explain how Ingersoll Rand uses non-GAAP financial measures such as Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Diluted EPS, Free Cash Flow, and Free Cash Flow Margin. The company’s disclosures describe how these metrics are calculated, why management and the board use them, and how they relate to liquidity, capital allocation, and performance evaluation.
Stock Titan enhances these regulatory documents with AI-powered summaries that help interpret key points from lengthy filings. As new IR filings are posted to EDGAR, they are updated here, allowing investors to quickly locate quarterly results, material event disclosures, and governance updates. Users interested in topics such as segment performance, capital allocation, director appointments, or the company’s use of non-GAAP metrics can use this page as a central reference for Ingersoll Rand’s official SEC reporting history.
Ingersoll Rand Inc. reported that officer Matthew J. Emmerich acquired equity-based compensation through awards of 3,060 Restricted Stock Units and 7,581 stock options. The RSUs and options vest in four equal annual installments beginning on February 23, 2027, with RSUs settling in shares, cash, or a combination.
Ingersoll Rand Inc. officer Elizabeth Meloy Hepding reported multiple equity compensation transactions involving restricted stock units (RSUs), stock options, and common shares. On February 22, 2026, 618 RSUs were converted into the same number of common shares, with 268 shares withheld to cover taxes tied to vesting. On February 23, 2026, another 594 RSUs were converted into common stock and 258 shares were withheld for taxes.
Also on February 23, she received new awards of 4,456 RSUs and 11,042 stock options, both vesting in four annual installments beginning on February 23, 2027. After these transactions, she directly held 16,886 shares of common stock.
Ingersoll Rand Inc. officer Kathleen M. Keene reported multiple equity transactions tied to stock awards. On February 23, 2026, she acquired 5,055 restricted stock units and 12,525 stock options (right to buy) at a stated price of $0.00 per unit, all held directly. That same day, 648 restricted stock units vested and were converted into 648 common shares, with 184 shares withheld at
Ingersoll Rand Inc. Senior Vice President and CFO Vikram Kini reported equity compensation activity involving restricted stock units, stock options, and related common stock. Previously granted restricted stock units vested into 1,943 and 1,648 shares of common stock, while 843 and 715 shares were disposed of to cover tax withholding obligations at prices of
Ingersoll Rand Inc. director John Humphrey reported an open-market sale of 4,300 shares of common stock at a weighted average price of $95.90 per share. After this transaction, he directly holds 23,983 shares of Ingersoll Rand common stock. The sale price reflects multiple trades within a narrow range between $95.89 and $95.96.
Ingersoll Rand Inc. Senior Vice President and CFO Vikram Kini reported multiple equity transactions dated February 20, 2026. He exercised two tranches of stock options for 14,132 and 14,235 shares of common stock at exercise prices of $11.43 and $32.06 per share. These stock options were fully vested and exercisable. Following the exercises, he conducted an open-market sale of 28,367 shares of Ingersoll Rand common stock at a price of $96.50 per share, leaving him with 98,517 common shares held directly after the reported transactions.
Ingersoll Rand Inc. director and officer Vicente Reynal reported option exercises and share sales in company stock. On February 18, 2026, he exercised 900 stock options at an exercise price of
Issuer submitted a Form 144 notice reporting proposed sales of Common stock through Fidelity Brokerage Services LLC on 02/20/2026. The excerpt lists option grants dated 12/09/2016 and 02/22/2018 with associated numbers 14132 and 14235.
Ingersoll Rand Inc. VP and Chief Accounting Officer Michael J. Scheske reported option exercises and share sales. On February 17, 2026, he exercised stock options for 11,479 shares of common stock at $27.79 per share and 7,643 shares at $45.58 per share, with the options fully vested and exercisable. He then sold 11,479 shares at an open-market price of $97.11 per share and 7,643 shares at $98.50 per share. After these transactions, he directly owned 12,153.179 shares of Ingersoll Rand common stock.
Ingersoll Rand Inc. executive Elizabeth Meloy Hepding exercised stock options and sold shares on February 17, 2026. She exercised options for 18,246 shares of common stock at an exercise price of $49.52 per share, then sold 18,246 shares of common stock in an open-market transaction at $97.11 per share. After these transactions, she directly owned 16,200 shares of Ingersoll Rand common stock. The stock options exercised were fully vested and exercisable.